VivoSeq
Cardiovascular

Vascular Function

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Vascular Function is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

35

clinical trials

Completed25 · 71%
Recruiting5 · 14%
Unknown status3 · 9%
Terminated1 · 3%
Withdrawn1 · 3%

Trial Activity

35 trials

: Vascular Function in Health and Disease
Recruiting··Phase 1·NCT02966665·420 enrolled
Prenatal Aspirin and Postpartum Vascular Function
Recruiting··Phase 1·NCT05653973·60 enrolled
The Effect of Fasudil on Vascular Function in Humans
Completed··Phase 2·NCT00120718·60 enrolled
Effect of Vitamin D3 on Vascular Function
Completed··N/A·NCT00948298·130 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)